Mannitol Brain Relaxation Effect

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Mannitol is widely used in patients with elevated intracranial pressure. In neurosurgical field, especially in large size or with brain edema, it is necessary to decrease brain volume to facilitate surgical approach. In general, 0.25 -1.5g of mannitol per kilogram has been known to decrease ICP effectively. But there are some debates in regard to appropriate dose of mannitol.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Mannitol

Criteria

Inclusion Criteria:

• Patients who underwent craniotomy for supratentorial brain tumor under general anesthesia

Exclusion Criteria:

• Patient who does not agree to the study

• Patients with or American Society of Anesthesiologists (ASA) physical status class IV or more

• Patients with glasgow coma scale (GCS) under 13 points

• Patients who have hyponatremia or hypernatremia (Na<130 or >150mEq/L)

• Patients who have congestive heart failure or moderately decreased renal function (GFR <60ml/min/1.73m2)

• Patients with extraventricular drainage such as external ventricular drain (EVD) or ventriculoperitoneal (VP) shunt

• Patients who already under mannitolization